Yea And Nay

One bravo and two boos for your Oct. 2, 1989, issue. The bravo is for the article “Science Fellows Lend Expertise While Learning Politics” [page 17], which was very well done. One aspect that you did not mention, however, is that the midcareer fellows who return to their. former institutions (often a tenured position at a university) may be unsatisfied and have trouble readjusting to that life. Midcareer scientists contemplating applying for one of those fellowships should be forew

Written byJudith Weis
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

One bravo and two boos for your Oct. 2, 1989, issue. The bravo is for the article “Science Fellows Lend Expertise While Learning Politics” [page 17], which was very well done. One aspect that you did not mention, however, is that the midcareer fellows who return to their. former institutions (often a tenured position at a university) may be unsatisfied and have trouble readjusting to that life. Midcareer scientists contemplating applying for one of those fellowships should be forewarned that a fellowship year may trigger a midlife crisis.

And now for the boos: The article “New Biomed Labs To Explore Oceans In Pursuit Of Knowledge And Profit” [page 2] had a major. blooper in it. Perhaps author Rex Dalton thinks that Xenopus is a sea urchin, but it certainly would be quite a feat of genetic engineering to turn a frog into a sea urchin.

Furthermore, the article “Six Receive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies